Kite Pharma, Inc. Accumulated Other Comprehensive Income
Kite Pharma, Inc. had Accumulated Other Comprehensive Income of -$297.00 thousand as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2017-08-08
- 2017-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$297.00K.
- 2017-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$686.00K.
- 2016-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$917.00K.
- 2016-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $675.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2017-06-30 | -$297.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$686.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$917.00K 10-Q · filed 2017-08-08 |
| 2016-09-30 | $675.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $762.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $1.02M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$220.00K 10-K · filed 2017-02-28 |
| 2015-09-30 | $472.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $340.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$207.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$297.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | -$107.00K 10-Q · filed 2014-11-14 |